163 related articles for article (PubMed ID: 38239932)
1. Probing Adenosine and P2 Receptors: Design of Novel Purines and Nonpurines as Selective Ligands.
Jacobson KA
Drug Dev Res; 2001; 52(1-2):178-186. PubMed ID: 38239932
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
Li AH; Moro S; Melman N; Ji XD; Jacobson KA
J Med Chem; 1998 Aug; 41(17):3186-201. PubMed ID: 9703464
[TBL] [Abstract][Full Text] [Related]
3. Acyl-Hydrazide Derivatives of a Xanthine Carboxylic Congener (XCC) as Selective Antagonists at Human A
Kim YC; Karton Y; Ji XD; Melman N; Linden J; Jacobson KA
Drug Dev Res; 1999 Aug; 47(4):178-188. PubMed ID: 35790094
[TBL] [Abstract][Full Text] [Related]
4. A
Jacobson KA; Moro S; Kim YC; Li AH
Drug Dev Res; 1998; 45(3-4):113-124. PubMed ID: 31808655
[TBL] [Abstract][Full Text] [Related]
5. Pyran Template Approach to the Design of Novel A
Li AH; Ji XD; Kim HS; Melman N; Jacobson KA
Drug Dev Res; 1999 Dec; 48(4):171-177. PubMed ID: 27182099
[TBL] [Abstract][Full Text] [Related]
6. Engineering of A
Jacobson KA; Kim HS; Ravi G; Kim SK; Lee K; Chen A; Chen W; Kim SG; Barak D; Liang BT; Gao ZG
Drug Dev Res; 2003 Apr; 58(4):330-339. PubMed ID: 35799977
[TBL] [Abstract][Full Text] [Related]
7. Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary.
Gao ZG; Kim SK; Biadatti T; Chen W; Lee K; Barak D; Kim SG; Johnson CR; Jacobson KA
J Med Chem; 2002 Sep; 45(20):4471-84. PubMed ID: 12238926
[TBL] [Abstract][Full Text] [Related]
8. Selective A(3) adenosine receptor antagonists derived from nucleosides containing a bicyclo[3.1.0]hexane ring system.
Melman A; Wang B; Joshi BV; Gao ZG; Castro Sd; Heller CL; Kim SK; Jeong LS; Jacobson KA
Bioorg Med Chem; 2008 Sep; 16(18):8546-56. PubMed ID: 18752961
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological activity, and molecular modeling of ribose-modified deoxyadenosine bisphosphate analogues as P2Y(1) receptor ligands.
Nandanan E; Jang SY; Moro S; Kim HO; Siddiqui MA; Russ P; Marquez VE; Busson R; Herdewijn P; Harden TK; Boyer JL; Jacobson KA
J Med Chem; 2000 Mar; 43(5):829-42. PubMed ID: 10715151
[TBL] [Abstract][Full Text] [Related]
10. Purine derivatives as ligands for A3 adenosine receptors.
Joshi BV; Jacobson KA
Curr Top Med Chem; 2005; 5(13):1275-95. PubMed ID: 16305531
[TBL] [Abstract][Full Text] [Related]
11. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
Hayallah AM; Sandoval-Ramírez J; Reith U; Schobert U; Preiss B; Schumacher B; Daly JW; Müller CE
J Med Chem; 2002 Mar; 45(7):1500-10. PubMed ID: 11906291
[TBL] [Abstract][Full Text] [Related]
12. Ribose modified nucleosides and nucleotides as ligands for purine receptors.
Jacobson KA; Ravi RG; Nandanan E; Kim HS; Moro S; Kim YC; Lee K; Barak D; Marquez VE; Ji XD
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):333-41. PubMed ID: 11563046
[TBL] [Abstract][Full Text] [Related]
13. 6-phenyl-1,4-dihydropyridine derivatives as potent and selective A3 adenosine receptor antagonists.
Jiang JL; van Rhee AM; Melman N; Ji XD; Jacobson KA
J Med Chem; 1996 Nov; 39(23):4667-75. PubMed ID: 8917655
[TBL] [Abstract][Full Text] [Related]
14. 2-Phenylimidazo[2,1-i]purin-5-ones: structure-activity relationships and characterization of potent and selective inverse agonists at Human A3 adenosine receptors.
Ozola V; Thorand M; Diekmann M; Qurishi R; Schumacher B; Jacobson KA; Müller CE
Bioorg Med Chem; 2003 Feb; 11(3):347-56. PubMed ID: 12517430
[TBL] [Abstract][Full Text] [Related]
15. Interaction of 1,4-dihydropyridine and pyridine derivatives with adenosine receptors: selectivity for A3 receptors.
van Rhee AM; Jiang JL; Melman N; Olah ME; Stiles GL; Jacobson KA
J Med Chem; 1996 Jul; 39(15):2980-9. PubMed ID: 8709132
[TBL] [Abstract][Full Text] [Related]
16. 2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation: enhanced potency as P2Y1 receptor antagonists.
Kim HS; Ohno M; Xu B; Kim HO; Choi Y; Ji XD; Maddileti S; Marquez VE; Harden TK; Jacobson KA
J Med Chem; 2003 Nov; 46(23):4974-87. PubMed ID: 14584948
[TBL] [Abstract][Full Text] [Related]
17. Development of selective high affinity antagonists, agonists, and radioligands for the P2Y1 receptor.
Houston D; Costanzi S; Jacobson KA; Harden TK
Comb Chem High Throughput Screen; 2008 Jul; 11(6):410-9. PubMed ID: 18673269
[TBL] [Abstract][Full Text] [Related]
18. Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists.
Jacobson KA; Ji X; Li AH; Melman N; Siddiqui MA; Shin KJ; Marquez VE; Ravi RG
J Med Chem; 2000 Jun; 43(11):2196-203. PubMed ID: 10841798
[TBL] [Abstract][Full Text] [Related]
19. Rigidified A3 Adenosine Receptor Agonists: 1-Deazaadenine Modification Maintains High in Vivo Efficacy.
Tosh DK; Crane S; Chen Z; Paoletta S; Gao ZG; Gizewski E; Auchampach JA; Salvemini D; Jacobson KA
ACS Med Chem Lett; 2015 Jul; 6(7):804-8. PubMed ID: 26191370
[TBL] [Abstract][Full Text] [Related]
20. Probing Substituents in the 1- and 3-Position: Tetrahydropyrazino-Annelated Water-Soluble Xanthine Derivatives as Multi-Target Drugs With Potent Adenosine Receptor Antagonistic Activity.
Koch P; Brunschweiger A; Namasivayam V; Ullrich S; Maruca A; Lazzaretto B; Küppers P; Hinz S; Hockemeyer J; Wiese M; Heer J; Alcaro S; Kiec-Kononowicz K; Müller CE
Front Chem; 2018; 6():206. PubMed ID: 29998095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
